Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells

Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells

Item
http://www.wikidata.org/entity/Q24619895
Dry eye: an inflammatory ocular diseasePractical issues concerning tear protein assays in dry eyeIn Silico Screening Reveals Structurally Diverse, Nanomolar Inhibitors of NQO2 That Are Functionally Active in Cells and Can Modulate NF- B SignalingOcular surface immunity: homeostatic mechanisms and their disruption in dry eye disease17-β-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cellsIn Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived CellsEffects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients.Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1).Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.The transrepression arm of glucocorticoid receptor signaling is protective in mutant huntingtin-mediated neurodegeneration.Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cellsAnti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells
P2860

Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells

Item
http://www.wikidata.org/entity/Q24619895
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Mapracorat, a novel selective ...... human corneal epithelial cells
@ast
Mapracorat, a novel selective ...... human corneal epithelial cells
@en
Mapracorat, a novel selective ...... human corneal epithelial cells
@nl
type
label
Mapracorat, a novel selective ...... human corneal epithelial cells
@ast
Mapracorat, a novel selective ...... human corneal epithelial cells
@en
Mapracorat, a novel selective ...... human corneal epithelial cells
@nl
prefLabel
Mapracorat, a novel selective ...... human corneal epithelial cells
@ast
Mapracorat, a novel selective ...... human corneal epithelial cells
@en
Mapracorat, a novel selective ...... human corneal epithelial cells
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P577
P698
P921
P932
P3181
P356
P1433
P1476
Mapracorat, a novel selective ...... human corneal epithelial cells
@en
P2093
P2860
P304
P31
P3181
P356
10.1111/J.1755-3768.2011.4343.X
P407
P478
P577
P698
P921
P932